Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-07

FDA Approved: FLUTICASONE FUROATE ELLIPTA — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for Fluticasone Furoate Ellipta submitted by Prasco Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone furoate Ellipta (Fluticasone furoate)

Snippet

SUPPL AP for FLUTICASONE FUROATE ELLIPTA (FLUTICASONE FUROATE)